ImmuCell Corporation Ownership (ICCC)

USA |NASDAQ |USD

Immucell Corporation Ownership Highlights

Immucell Corporation (NASDAQ:ICCC) is owned by 11.45% institutional shareholders and by 28.46% insiders. The rest is owned by the public.

The largest institutional owner of Immucell Corporation is "Renaissance Technologies Corp", owning 2.28% of the company's total share outstanding.

The largest mutual fund owner of Immucell Corporation is "Vanguard Total Stock Mkt Idx Inv", owning 1.02% of the company's total share outstanding.

Institutional Owners of Immucell Corporation

The top 10 institutional shareholders of Immucell Corporation together own 727.67K shares, representing 9.40% of Immucell Corporation's total shares outstanding.

The table below contains a list of the top institutional shareholders of ICCC.

Name Shares % of Shares Out % of Total Assets Managed Change (Shares) Change %
Renaissance Technologies Corp 176.32K 2.28% 0.00% -1.83K -1.03%
Vanguard Group Inc 147.24K 1.90% - - -
Meristem, LLP 85.52K 1.10% 0.08% 85.52K -
Overbrook Management Corp 82.12K 1.06% 0.17% -5.10K -5.85%
Bleichroeder LP 60.61K 0.78% 0.09% - -
Morgan Stanley - Brokerage Accounts 52.88K 0.68% 0.00% -3.00K -5.37%
Perritt Capital Management Inc. 50.00K 0.65% 0.26% - -
Strategic Investment Advisors Inc 30.03K 0.39% 0.02% - -
Geode Capital Management, LLC 22.44K 0.29% - 2.01K 9.83%
Dimensional Fund Advisors, Inc. 20.51K 0.27% 0.00% 1.11K 5.70%

Mutual Funds Holding Immucell Corporation

The top 10 mutual funds shareholders of Immucell Corporation together hold 248.59K shares, representing 3.21% of Immucell Corporation's total shares outstanding.

The table below contains a list of the top mutual funds holding ICCC.

Owner Name Shares % of Shares Out % of Total Assets Managed Change (Shares) Change %
Vanguard Total Stock Mkt Idx Inv 79.04K 1.02% 0.00% - -
Vanguard Extended Market Index Investor 66.37K 0.86% 0.00% - -
Perritt Ultra MicroCap 50.00K 0.65% 2.22% - -
iShares Micro-Cap ETF 13.34K 0.17% 0.01% - -
Fidelity® Extended Market Index 13.12K 0.17% 0.00% - -
Fidelity® Series Total Market Index 7.19K 0.09% 0.00% - -
DFA US Core Equity 2 I 6.24K 0.08% 0.00% - -
Northern Trust Extended Eq Market Idx 4.63K 0.06% 0.00% - -
NT Ext Equity Mkt Idx Fd - L 4.63K 0.06% 0.00% - -
NT Ext Equity Mkt Idx Fd - NL 4.03K 0.05% 0.00% - -

Insider Transactions

Transaction Date Insider Name Buy/ Sell Number of Shares Price Shares Held After Transaction Details
Mar 12, 2020 David Cunningham Buy 2.00K $4.00 15.00K Details
Feb 27, 2020 David Scott Tomsche Buy 5.13K $4.98 Details
Aug 16, 2018 David Scott Tomsche Buy 3.00K $6.67 Details
Jul 27, 2017 Brian L Pessin Buy 30.00K $5.25 70.00K Details
Mar 14, 2017 David Scott Tomsche Buy 2.00K $5.43 71.28K Details
Nov 7, 2016 David Scott Tomsche Buy 4.00K $5.19 Details
Jul 8, 2016 Joseph H Crabb Sell 1.94K $6.55 106.70K Details
Jul 7, 2016 Joseph H Crabb Sell 2.69K $6.58 108.84K Details
Jul 5, 2016 Joseph H Crabb Sell 5.37K $6.74 115.04K Details
Mar 21, 2016 David Scott Tomsche Buy 955.00 $6.67 66.79K Details

Immucell Corporation Ownership: A Close Look

Immucell Corporation's Largest Institutional Shareholders

The largest institutional shareholders of Immucell Corporation are "Renaissance Technologies Corp", "Vanguard Group Inc" and "Meristem, LLP". Those three own together 5.28% of ICCC's total shares outstanding.

1. Renaissance Technologies Corp

Renaissance Technologies is a quantitative investment management company trading in global financial markets, dedicated to producing exceptional returns for its investors by strictly adhering to mathematical and statistical methods. As of April 2021, The fund manages US$165 billion.

The company owns 176.32K shares of Immucell Corporation, representing 2.28% of ICCC's total share outstanding. Using the last stock closing price of $9.10, Renaissance Technologies Corp's current total stake in Immucell Corporation is worth $1.60M.

2. Vanguard Group Inc

Vanguard is one of the world's largest investment companies, offering a large selection of low-cost mutual funds, ETFs, advice, and related services. As of January 31, 2021, Vanguard's asset under management totaled US$7.2 trillion. The company manages 209 U.S. funds and about 232 additional funds in markets outside the United States. Vanguard has more than 30 million investors, in about 170 countries.

The company owns 147.24K shares of Immucell Corporation, representing 1.90% of ICCC's total share outstanding. Using the last stock closing price of $9.10, Vanguard Group Inc's current total stake in Immucell Corporation is worth $1.34M.

3. Meristem, LLP

The company owns 85.52K shares of Immucell Corporation, representing 1.10% of ICCC's total share outstanding. Using the last stock closing price of $9.10, Meristem, LLP's current total stake in Immucell Corporation is worth $778.22K.

Immucell Corporation's Largest Mutual Fund Holders

The largest mutual fund holders of Immucell Corporation are "Vanguard Total Stock Mkt Idx Inv", "Vanguard Extended Market Index Investor" and "Perritt Ultra MicroCap". Together these mutual funds hold 2.52% of Immucell Corporation's total share outstanding.

"Vanguard Total Stock Mkt Idx Inv" holds 79.04K shares, representing 1.02% of Immucell Corporation's total shares outstanding.

"Vanguard Extended Market Index Investor" holds 66.37K shares, representing 0.86% of Immucell Corporation's total shares outstanding.

"Perritt Ultra MicroCap" holds 50.00K shares, representing 0.65% of Immucell Corporation's total shares outstanding.